CVS Health (CVS) Insider Trading & Ownership $44.36 +0.58 (+1.32%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CVS Health (NYSE:CVS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.24%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$53,880.00Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$2.27 M Get CVS Insider Trade Alerts Want to know when executives and insiders are buying or selling CVS Health stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CVS Insider Buying and Selling by Quarter Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover CVS Health Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/24/2024Thomas R. SuozziU.S. Congress Member (D-NY)Sell$56.11$1,001 - $15,0008/26/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$58.70$1,001 - $15,0006/27/2024Earl BlumenauerU.S. Congress Member (D-OR)Sell$58.37$1,001 - $15,0005/17/2024William R. KeatingU.S. Congress Member (D-MA)Sell$57.68$1,001 - $15,0005/2/2024Edward J LudwigDirectorBuy1,000$53.88$53,880.00 2/16/2024Prem S ShahEVPSell29,473$76.95$2,267,947.35 (Data available from 1/1/2013 forward) CVS Insider Trading Activity - Frequently Asked Questions Who is on CVS Health's Insider Roster? The list of insiders at CVS Health includes Alan Lotvin, Daniel P Finke, Edward J Ludwig, James David Clark, Jonathan C Roberts, Karen S Lynch, Prem S Shah, Thomas M Moriarty, and Troyen A Brennan. Learn more on insiders at CVS. What percentage of CVS Health stock is owned by insiders? 0.24% of CVS Health stock is owned by insiders. Learn more on CVS's insider holdings. Which CVS Health insiders have been buying company stock? The following insiders have purchased CVS shares in the last 24 months: Edward J Ludwig ($194,820.00), and Karen S Lynch ($976,500.00). How much insider buying is happening at CVS Health? Insiders have purchased a total of 17,000 CVS shares in the last 24 months for a total of $1,171,320.00 bought. Which CVS Health insiders have been selling company stock? The following insiders have sold CVS shares in the last 24 months: James David Clark ($1,929,864.28), and Prem S Shah ($2,267,947.35). How much insider selling is happening at CVS Health? Insiders have sold a total of 55,232 CVS Health shares in the last 24 months for a total of $4,197,811.63 sold. Which members of congress are trading CVS Health? Thomas R. Suozzi (D-NY), Tommy Tuberville (R-AL), Earl Blumenauer (D-OR), and William R. Keating (D-MA) have sold shares of CVS Health in the last year totaling $32,000. CVS Health Key ExecutivesMs. Karen Sue Lynch (Age 61)President, CEO & Director Compensation: $5.12MMr. Thomas Francis Cowhey (Age 52)Executive VP & CFO Compensation: $1.83MMr. Tilak Mandadi (Age 59)Executive VP of Ventures and Chief Digital, Data, Analytics & Technology Officer Compensation: $2.38MMr. Samrat S. Khichi Esq. (Age 57)Executive VP, Chief Policy Officer & General Counsel Compensation: $3.39MMr. Prem S. Shah Pharm.D (Age 44)Executive VP, Chief Pharmacy Officer and President of Pharmacy & Consumer Wellness Compensation: $2.58MMr. Vijay PatelSenior Director of Business Development & CVS Health and Partner & Co-FounderMr. James David Clark (Age 59)Senior VP, Controller & Chief Accounting Officer Mr. David A. FalkowskiExecutive VP & Chief Compliance OfficerMs. Heidi B. Capozzi (Age 54)Executive VP & Chief People Officer Mr. J. David Joyner CEBS (Age 59)Executive Vice President & President of CVS Caremark More Insider Trading Tools from MarketBeat Related Companies Walgreens Boots Alliance Insider Buying Guardian Pharmacy Services Insider Buying PetMed Express Insider Buying McDonald's Insider Buying Alibaba Group Insider Buying Booking Insider Buying Lowe's Companies Insider Buying TJX Companies Insider Buying Starbucks Insider Buying MercadoLibre Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NYSE:CVS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVS Health Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVS Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
